TWO SIGMA ADVISERS, LP - NEOLEUKIN THERAPEUTICS INC ownership

NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 87 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of NEOLEUKIN THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$153,135
-6.6%
184,500
-21.2%
0.00%
Q1 2023$163,940
+28.7%
234,200
-6.4%
0.00%
Q4 2022$127,403
-49.4%
250,300
-36.5%
0.00%
-100.0%
Q3 2022$252,000
-36.8%
394,000
+1.7%
0.00%0.0%
Q2 2022$399,000
-26.5%
387,600
+34.1%
0.00%0.0%
Q1 2022$543,000
-52.0%
289,000
+23.1%
0.00%
-66.7%
Q4 2021$1,131,000
-10.4%
234,700
+34.4%
0.00%0.0%
Q3 2021$1,262,000
+129.0%
174,600
+192.5%
0.00%
+200.0%
Q2 2021$551,000
-44.2%
59,700
-25.7%
0.00%
-66.7%
Q1 2021$988,000
-47.4%
80,300
-39.7%
0.00%
-40.0%
Q4 2020$1,877,000
+96.3%
133,100
+67.0%
0.01%
+66.7%
Q3 2020$956,000
+48.9%
79,700
+105.9%
0.00%
+50.0%
Q2 2020$642,000
+184.1%
38,700
+94.5%
0.00%
+100.0%
Q1 2020$226,000
-31.5%
19,900
-25.7%
0.00%0.0%
Q4 2019$330,000
+202.8%
26,800
-30.2%
0.00%
Q3 2019$109,00038,4000.00%
Other shareholders
NEOLEUKIN THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,386,300$19,547,0002.55%
EcoR1 Capital, LLC 3,122,704$44,030,0002.37%
Redmile Group, LLC 4,131,869$58,259,0000.70%
Boxer Capital, LLC 1,501,058$21,165,0000.68%
HighVista Strategies LLC 69,727$983,0000.63%
Baker Brothers Advisors 3,821,740$53,887,0000.20%
Highland Private Wealth Management 93,998$1,326,0000.12%
Sio Capital Management, LLC 38,312$540,0000.11%
Point72 Asset Management, L.P. 1,195,725$16,860,0000.08%
Granahan Investment Management 246,299$3,473,0000.08%
View complete list of NEOLEUKIN THERAPEUTICS INC shareholders